Group 1 - The 2025 China Biomaterials Conference was held in Shaoxing, Zhejiang [1] - The event showcased various exhibitors presenting their products and new technologies [2][4] - Attendees engaged with exhibits, including a demonstration of a biological 3D printer [5][6] Group 2 - The conference attracted a large number of visitors, indicating strong interest in the biomaterials sector [7] - The opening ceremony featured significant participation from industry leaders and stakeholders [9]

Core Insights - The rapid advancements in biomedical engineering are reshaping the future of human health, with innovations such as 3D bioprinting of organs and tissues becoming increasingly feasible [3][20] - Significant breakthroughs include the successful cultivation of a living heart organoid and the discovery of a molecular switch for organ regeneration in mammals [1][4] Group 1: Innovations in Biomedical Engineering - The first living heart organoid over 1 cm in diameter was successfully cultivated in Shanghai, offering new hope for organ transplantation [1][4] - Researchers have developed a method to 3D print active organoids using bioprinting technology, which can replicate the structure and function of real organs [4][20] - The production of bioprinting materials involves creating billions of living cells, which are cultivated in specialized environments to ensure rapid and large-scale expansion [6][8] Group 2: Applications of Bioprinting - Bioprinting technology is being utilized for drug testing, allowing for the creation of mini-tumor models that can simulate patient responses to various treatments [16][18] - The development of in-situ printing techniques enables the direct repair of damaged tissues within the body, such as printing new skin or heart patches [18][20] Group 3: Cross-Disciplinary Collaborations - Collaborative efforts among multiple research institutions have led to the creation of a novel visual prosthetic that allows blind animals to perceive infrared light, showcasing the potential of interdisciplinary research in biomedical engineering [21][27] - The integration of nanomaterials and advanced engineering techniques has resulted in significant improvements in the functionality and efficiency of bioelectronic devices [25][27] Group 4: Strategic Development in Life Sciences - The Chinese government is prioritizing life sciences in its strategic development plans, with initiatives aimed at accelerating the commercialization of cutting-edge technologies in cell and gene therapy [28] - Cities like Shanghai and Shenzhen are actively fostering innovation ecosystems around organoids and biomanufacturing, with ambitious targets for the growth of the biopharmaceutical industry [28]

Group 1: Biomedical Engineering Innovations - Recent advancements in biomedical engineering are reshaping the future of health, with innovations such as 3D printed organs and smart prosthetics [3][12] - In June 2025, a research team in China discovered a "molecular switch" for mammalian organ regeneration, enabling injured adult mice to regrow ear cartilage and nerve tissue [1] - The world's first living heart organoid, over 1 centimeter in diameter, was successfully cultivated in Shanghai, derived from human stem cells, offering new hope for organ transplantation [1][4] Group 2: Organoid Technology and Applications - Organoids are miniaturized organ models created from stem cells that can simulate real organ structures and functions, useful for disease modeling and drug screening [4][11] - The process of 3D printing active organoids requires billions of cells, with advancements in bioprinting technology allowing for the creation of complex structures [5][9] - Current applications include printing skin, cartilage, and small organoids for clinical use, while more complex organ printing is still in research stages [11][12] Group 3: Drug Testing and Personalized Medicine - High-throughput organoid printing technology allows for the simulation of cancer patient tumors, enabling efficient drug testing without the need for blind trials on patients [14] - This method allows for simultaneous testing of multiple drugs and dosages, streamlining the process of finding effective treatment options [14] Group 4: Cross-Disciplinary Collaborations - Recent developments in vision prosthetics demonstrate the potential of interdisciplinary collaboration, with a team creating a wide-spectrum visual prosthetic that enables blind animals to perceive infrared light [17][18] - The project involved multiple national key laboratories, showcasing a new paradigm of innovation in biomedical engineering through cross-laboratory cooperation [24] Group 5: Strategic Industry Development - Shanghai has initiated an innovation ecosystem for organoids since 2021, focusing on drug screening and personalized medicine [26] - Hubei aims to grow its biopharmaceutical industry to 250 billion by 2027, emphasizing organoid technology as a key direction [26] - Shenzhen has included cutting-edge fields like cell therapy and gene therapy in its support measures for the pharmaceutical and medical device sectors [26]

作 者丨柳宁馨 编 辑丨李博 视 频丨柳润瑛 实习生余星惠 今年以来，De e pSe e k等杭州"六小龙"备受关注，引发各地城市对自身产业创新发展的反思浪 潮，形成了产业创新发展的"杭州效应"。 "杭州效应"背后，一是外界纷纷关注杭州为何能诞生如此多的科创企业，二是跳出杭州看， 着力推动科技创新与产业创新融合发展，成为当前城市发展的一大趋势。 2 1世纪经济报道记者近期走访杭州余杭、滨江、拱墅、钱塘、富阳等产业强区发现，杭州在 全国较早开启招才引智体系化工作，又回归市场逻辑，让科创企业在适宜的产业生态中迅速 壮大。经过优势产业迭代，杭州科创产业集聚区的作用日渐明显，良性循环的产业生态又吸 引更多科创企业加入。 杭州高新区（滨江）在全省最早推出高层次人才创业支持政策" 5 0 5 0计划"，每年引进人才超4 万，人才总量超5 0万。目前，杭州高新区（滨江）已经是浙江省数字经济第一区、浙江省上 市 公 司 第 一 区 ， 2 0 2 4 年 全 区 实 现 GDP2 8 8 7 亿 元 ， 已 累 计 培 育 上 市 公 司 7 4 家 ， 拥 有 专 精 特 新"小巨人"企业1 0 0家，国高企超过2 8 ...